search

Total posts by Harvard Medical School: 6

publication · 7 months ago
PSMA-targeted contrast agents for intraoperative imaging of prostate cancer
by Jeong Heon Lee, Kai Bao, Georges El Fakhri, Hak Soo Choi, Homan Kang, Kate Park (Harvard Medical School, Massachusetts General Hospital, Shenyang Pharmaceutical University)
publication · 7 months ago
Site-Specific In Vivo Bioorthogonal Ligation via Chemical Modulation
by Heebeom Koo, Jeong Heon Lee, Kai Bao, Yunshan Wu, Georges El Fakhri, Maged Henary, Seok Hyun Yun, Hak Soo Choi (Harvard Medical School, Massachusetts General Hospital, The Catholic University of Korea, Georgia State University, Gordon Center for Medical Imaging, Wellman Center for Photomedicine)
publication · 1 year ago
Bisphosphonate-Linked TrkB Agonist: Cochlea-Targeted Delivery of a Neurotrophic Agent as a Strategy for the Treatment of Hearing Loss
by Judith S. Kempfle, Kim Nguyen, Christine Hamadani, Nicholas Koen, Albert S. Edge, Boris A. Kashemirov, David H. Jung, Charles E. McKenna (Harvard Medical School, University of Tùˆbingen Medical Center, University of Southern California)
publication · 6 years ago
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery
by Daniel J. Siegwart, Kathryn A. Whitehead, Lutz Nuhn, Gaurav Sahay, Hao Cheng, Shan Jiang, Minglin Ma, Abigail Lytton-Jean, Arturo Vegas, Patrick Fenton, Christopher G. Levins, Kevin T. Love, Haeshin Lee, Christina Cortez, Sean P. Collins, Ying Fei Li (Harvard Medical School, Massachusetts Institute of Technology, Alnylam Pharmaceuticals, Harvard-MIT Division of Health Sciences and Technology)
publication · 7 years ago
A Concise Silylamine Approach to 2-Amino-3-hydroxy-indoles with Potent in vivo Antimalaria Activity
by Ralph Mazitschek, Sameer Urgaonkar, Joseph F. Cortese, Mandy Cromwell, Robert H. Barker, Dyann F. Wirth, Adelfa E. Serrano, Jon Clardy (Broad Institute, Harvard Medical School, University of Puerto Rico, Harvard School of Public Health, Massachusetts General Hospital, Genzyme Corporation)
presentation · 9 years ago
A Robotic Chemistry System for the Discovery of Cancer-Specific Targeting Ligands
by John Frangioni (Beth Israel Deaconess Medical Center, Harvard Medical School)